Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
![]() |
Cochlear Stem Cells/Progenitors and Degenerative Hearing DisordersCurrent medicinal chemistry, 2007-11, Vol.14 (27), p.2937-2943 [Peer Reviewed Journal]2008 INIST-CNRS ;Copyright © 2007 Bentham Science Publishers ;ISSN: 0929-8673 ;EISSN: 1875-533X ;DOI: 10.2174/092986707782360051 ;PMID: 18045139Full text available |
2 |
Material Type: Article
|
![]() |
Peginterferon alfa-2a: A review of approved and investigational usesClinical therapeutics, 2004-07, Vol.26 (7), p.991-1025 [Peer Reviewed Journal]2004 ;2004 INIST-CNRS ;Copyright Elsevier Limited Jul 2004 ;ISSN: 0149-2918 ;EISSN: 1879-114X ;DOI: 10.1016/S0149-2918(04)90173-7 ;PMID: 15336466Full text available |
3 |
Material Type: Article
|
![]() |
Planning experiments: Updated guidance on experimental design and analysis and their reporting IIIBritish journal of pharmacology, 2022-08, Vol.179 (15), p.3907-3913 [Peer Reviewed Journal]2022 The British Pharmacological Society. ;2022 The British Pharmacological Society ;ISSN: 0007-1188 ;EISSN: 1476-5381 ;DOI: 10.1111/bph.15868 ;PMID: 35673806Full text available |
4 |
Material Type: Article
|
![]() |
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Introduction and Other Protein TargetsBritish journal of pharmacology, 2021-10, Vol.178 (S1), p.S1-S26 [Peer Reviewed Journal]2021 The Authors. British Journal of Pharmacology published by John Wiley & Sons Ltd on behalf of The British Pharmacological Society ;ISSN: 0007-1188 ;EISSN: 1476-5381 ;DOI: 10.1111/bph.15537Full text available |
5 |
Material Type: Article
|
![]() |
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Nuclear hormone receptorsBritish journal of pharmacology, 2021-10, Vol.178 (S1), p.S246-S263 [Peer Reviewed Journal]2021 The Authors. British Journal of Pharmacology published by John Wiley & Sons Ltd on behalf of The British Pharmacological Society ;ISSN: 0007-1188 ;EISSN: 1476-5381 ;DOI: 10.1111/bph.15540Full text available |
6 |
Material Type: Article
|
![]() |
ARRIVE 2.0 and the British Journal of Pharmacology: Updated guidance for 2020British journal of pharmacology, 2020-08, Vol.177 (16), p.3611-3616 [Peer Reviewed Journal]2020 The British Pharmacological Society ;ISSN: 0007-1188 ;EISSN: 1476-5381 ;DOI: 10.1111/bph.15178 ;PMID: 32662875Full text available |
7 |
Material Type: Article
|
![]() |
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: EnzymesBritish journal of pharmacology, 2021-10, Vol.178 (S1), p.S313-S411 [Peer Reviewed Journal]2021 The Authors. British Journal of Pharmacology published by John Wiley & Sons Ltd on behalf of The British Pharmacological Society ;ISSN: 0007-1188 ;EISSN: 1476-5381 ;DOI: 10.1111/bph.15542Full text available |
8 |
Material Type: Article
|
![]() |
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Catalytic receptorsBritish journal of pharmacology, 2021-10, Vol.178 (S1), p.S264-S312 [Peer Reviewed Journal]2021 The Authors. British Journal of Pharmacology published by John Wiley & Sons Ltd on behalf of The British Pharmacological Society ;ISSN: 0007-1188 ;EISSN: 1476-5381 ;DOI: 10.1111/bph.15541Full text available |
9 |
Material Type: Article
|
![]() |
A practical guide for transparent reporting of research on natural products in the British Journal of Pharmacology: Reproducibility of natural product researchBritish journal of pharmacology, 2020-05, Vol.177 (10), p.2169-2178 [Peer Reviewed Journal]2020 The British Pharmacological Society ;ISSN: 0007-1188 ;EISSN: 1476-5381 ;DOI: 10.1111/bph.15054 ;PMID: 32298474Full text available |
10 |
Material Type: Article
|
![]() |
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: TransportersBritish journal of pharmacology, 2021-10, Vol.178 (S1), p.S412-S513 [Peer Reviewed Journal]2021 The Authors. British Journal of Pharmacology published by John Wiley & Sons Ltd on behalf of The British Pharmacological Society ;ISSN: 0007-1188 ;EISSN: 1476-5381 ;DOI: 10.1111/bph.15543Full text available |
11 |
Material Type: Article
|
![]() |
PROTAC targeted protein degraders: the past is prologueNature reviews. Drug discovery, 2022-03, Vol.21 (3), p.181-200 [Peer Reviewed Journal]2022. Springer Nature Limited. ;Springer Nature Limited 2022 ;ISSN: 1474-1776 ;EISSN: 1474-1784 ;DOI: 10.1038/s41573-021-00371-6 ;PMID: 35042991Full text available |
12 |
Material Type: Article
|
![]() |
Challenges and opportunities in the PD1/PDL1 inhibitor clinical trial landscapeNature reviews. Drug discovery, 2022-07, Vol.21 (7), p.482-483 [Peer Reviewed Journal]Springer Nature Limited 2022. ;ISSN: 1474-1776 ;EISSN: 1474-1784 ;DOI: 10.1038/d41573-022-00030-4 ;PMID: 35145263Full text available |
13 |
Material Type: Article
|
![]() |
JAK inhibition as a therapeutic strategy for immune and inflammatory diseasesNature reviews. Drug discovery, 2018-01, Vol.17 (1), p.78-78 [Peer Reviewed Journal]COPYRIGHT 2018 Nature Publishing Group ;Copyright Nature Publishing Group Jan 2018 ;ISSN: 1474-1776 ;EISSN: 1474-1784 ;DOI: 10.1038/nrd.2017.267 ;PMID: 29282366Full text available |
14 |
Material Type: Article
|
![]() |
THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Introduction and Other Protein TargetsBritish journal of pharmacology, 2019-12, Vol.176 (S1), p.S1-S20 [Peer Reviewed Journal]2019 The Authors. British Journal of Pharmacology published by John Wiley & Sons Ltd on behalf of The British Pharmacological Society. ;2019. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0007-1188 ;EISSN: 1476-5381 ;DOI: 10.1111/bph.14747 ;PMID: 31710719Full text available |
15 |
Material Type: Article
|
![]() |
Antisense technology: an overview and prospectusNature reviews. Drug discovery, 2021-06, Vol.20 (6), p.427-453 [Peer Reviewed Journal]COPYRIGHT 2021 Nature Publishing Group ;Springer Nature Limited 2021. ;ISSN: 1474-1776 ;EISSN: 1474-1784 ;DOI: 10.1038/s41573-021-00162-z ;PMID: 33762737Full text available |
16 |
Material Type: Article
|
![]() |
Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewersBritish journal of pharmacology, 2018-04, Vol.175 (7), p.987-993 [Peer Reviewed Journal]2018 The British Pharmacological Society ;2018 The British Pharmacological Society. ;ISSN: 0007-1188 ;EISSN: 1476-5381 ;DOI: 10.1111/bph.14153 ;PMID: 29520785Full text available |
17 |
Material Type: Article
|
![]() |
The foundations of immune checkpoint blockade and the ipilimumab approval decennialNature reviews. Drug discovery, 2022-07, Vol.21 (7), p.509-528 [Peer Reviewed Journal]2021. Springer Nature Limited. ;Springer Nature Limited 2021. corrected publication 2022. ;ISSN: 1474-1776 ;EISSN: 1474-1784 ;DOI: 10.1038/s41573-021-00345-8 ;PMID: 34937915Full text available |
18 |
Material Type: Article
|
![]() |
Evolution of the COVID-19 vaccine development landscapeNature reviews. Drug discovery, 2020-10, Vol.19 (10), p.667-668 [Peer Reviewed Journal]COPYRIGHT 2020 Nature Publishing Group ;Nature 2020. ;ISSN: 1474-1776 ;EISSN: 1474-1784 ;DOI: 10.1038/d41573-020-00151-8Full text available |
19 |
Material Type: Article
|
![]() |
The role of the histamine H 4 receptor in atopic dermatitis and psoriasisBritish journal of pharmacology, 2020-02, Vol.177 (3), p.490-502 [Peer Reviewed Journal]2018 The British Pharmacological Society. ;ISSN: 0007-1188 ;EISSN: 1476-5381 ;DOI: 10.1111/bph.14550 ;PMID: 30460986Full text available |
20 |
Material Type: Article
|
![]() |
Spectrophotometric determination of acid dissociation constants of some arylpropionic acids and arylacetic acids in acetonitrile-water binary mixtures at 25ºCBrazilian Journal of Pharmaceutical Sciences, 2022, Vol.58 [Peer Reviewed Journal]This work is licensed under a Creative Commons Attribution 4.0 International License. ;ISSN: 2175-9790 ;EISSN: 2175-9790 ;DOI: 10.1590/s2175-97902022e20740Full text available |